Chronic Myeloid Leukemia Chronic Phase
📧 Sign up to get email alerts when something new happens for Chronic Myeloid Leukemia Chronic Phase.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Clinical Study of Asciminib in Previously Treated Indian Patients With Ph+ CML-CP Without T315I Mutation and in Patients With Ph+ CML-CP With T315I Mutation [Phase 4]
Phase 4 clinical trial of Asciminib in previously treated Indian patients with Philadelphia chromosome–positive chronic myeloid leukemia in …
-
CLINICAL_TRIALS trial_result · 2026-04-02Clinical Trial Update: Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors [Phase 2]
Phase 2 clinical trial examining a combination of ruxolitinib and tyrosine kinase inhibitors in chronic myeloid leukemia with reports of tre…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia [Phase 2]
A Phase 2 clinical trial in chronic myeloid leukemia, chronic phase, evaluating treatment-free remission, is currently recruiting in Korea.
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Dasatinib and Venetoclax in Treating Patients With Philadelphia Chromosome Positive or BCR-ABL1 Positive Early Chronic Phase Chronic Myelogenous Leukemia [Phase 2]
Phase 2 clinical trial evaluating the combination of dasatinib and venetoclax in patients with early chronic-phase Philadelphia chromosome-p…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: RWE,NIS,Prospective Study for the Effectiveness, Tolerability and Adherence of Asciminib in Saudi Arabia. (ASC4REAL)
Novartis is conducting ASC4REAL, a prospective real-world study of Asciminib in Saudi Arabia to evaluate effectiveness, tolerability, and ad…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Managed Access Programs for ABL001, Asciminib
The update describes managed access programs for asciminib (ABL001). These programs are intended to provide patient access for chronic myelo…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Ponatinib in Chronic Myeloid Leukemia Patients in Chronic Phase
This clinical trial update notes recruitment for ponatinib in patients with chronic myeloid leukemia in chronic phase at the University of P…
-
CLINICAL_TRIALS other · 2025-04-29Clinical Trial Update: MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing [NA]
Clinical trial update from the Medical College of Wisconsin describes a study using targeted antithymocyte globulin dosing to deplete alpha/…
-
CLINICAL_TRIALS research · 2024-12-31Clinical Trial Update: Study to Evaluate the Reinduction and Second Stop of TKI with Ponatinib in CML in Molecular Response (ResToP) [Phase 2]
Phase 2 clinical trial update for the ResToP study evaluating reinduction and a second stop of ponatinib therapy in chronic phase chronic my…
-
CLINICAL_TRIALS research · 2024-10-28Clinical Trial Update: Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China) [Phase 3]
Phase III randomized study evaluating radotinib versus imatinib in Chinese patients with chronic myeloid leukemia, chronic phase. The study …
-
CLINICAL_TRIALS trial_result · 2023-04-03Clinical Trial Update: A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Chronic Phase With T315I Mutation [Phase 2]
A pivotal Phase 2 study assessing HQP1351 in patients with chronic myeloid leukemia in chronic phase harboring the T315I mutation.
-
CLINICAL_TRIALS trial_result · 2022-12-06Clinical Trial Update: Cytochrome P450 Inhibition to Decrease Dosage of Dasatinib for Chronic Myelogenous Leukemia [Phase 2]
Phase 2 trial investigating cytochrome P450 inhibition to reduce dasatinib dosage in chronic myeloid leukemia (chronic phase).
-
CLINICAL_TRIALS trial_result · 2022-07-29Clinical Trial Update: Treatment With Olverembatinib in CML-CP Patients Who Failed to at Least Two Previously Administered Second-generation TKIs. [Phase 3]
Phase 3 clinical trial evaluating olverembatinib in chronic myeloid leukemia in chronic phase patients who failed at least two prior second-…
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Omega -3 Fatty Acid in Combination With Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia [Phase 1, Phase 2]
A combined Phase 1/2 trial evaluating Omega-3 fatty acid with tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia has been …
-
CLINICAL_TRIALS trial_result · 2022-05-10Clinical Trial Update: A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase [Phase 4]
Phase 4 real-world study comparing flumatinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase; currently not ye…
-
CLINICAL_TRIALS trial_result · 2022-04-29Clinical Trial Update: A Study of the Efficacy and Safety of Flumatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase. [Phase 4]
A phase 4 clinical trial evaluating the efficacy and safety of flumatinib in newly diagnosed chronic myeloid leukemia in chronic phase.
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: Nilotinib for First-line Newly Diagnosed CML-CP Patients [Phase 3]
Phase 3 trial update investigating nilotinib as first-line therapy for newly diagnosed chronic myeloid leukemia in the chronic phase.
-
CLINICAL_TRIALS trial_result · 2022-03-16Clinical Trial Update: Flumatinib in CML-CP Patients With Ph+ Post Imatinib Failure [Phase 4]
Phase 4 clinical trial update for flumatinib in chronic myeloid leukemia in the chronic phase after failure with imatinib.
-
CLINICAL_TRIALS trial_result · 2020-04-22Clinical Trial Update: Bosutinib in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase After Frontline TKI Failure [Phase 2]
A Phase 2 trial of bosutinib in chronic myeloid leukemia in chronic phase after frontline TKI failure has been terminated; results posted in…
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Chronic Myelod Leukemia Registry at Asan Medical Center
The Chronic Myeloid Leukemia Registry at Asan Medical Center has been terminated. The registry covers chronic myeloid leukemia in chronic ph…
-
CLINICAL_TRIALS trial_result · 2018-03-23Clinical Trial Update: Imatinib Discontinuation in Patients With Chronic Myeloid Leukemia Chronic Phase With Sustained MR4log [NA]
This clinical trial update discusses a study on discontinuing imatinib in patients with chronic myeloid leukemia in chronic phase who have s…
-
CLINICAL_TRIALS trial_result · 2017-11-06Clinical Trial Update: Efficacy and Safety of Nilotinib in CML-CP [Phase 4]
Phase 4 clinical trial evaluating the efficacy and safety of nilotinib in chronic myeloid leukemia, chronic phase.
-
CLINICAL_TRIALS trial_result · 2011-04-14Clinical Trial Update: BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia [Phase 1]
A Phase 1 study of BMS-354825 (dasatinib) in patients with chronic myeloid leukemia in chronic, accelerated, or blast phases and Philadelphi…